🛡️ GI Mucosal Protectant

Sucralfate for Dogs Dosage Calculator

Comprehensive sucralfate dosing for dogs — covering gastric ulcers, esophagitis, haemorrhagic gastroenteritis, and NSAID-associated GI protection, with administration timing, drug interaction spacing, and formulation guidance.

⏰

Timing is critical — give on an empty stomach. Sucralfate requires an acidic environment to form its protective gel. Give 1 hour before meals and at least 2 hours apart from other medications (including PPIs, H2 blockers, antacids, and fluoroquinolones which it binds and inactivates).

💊

About Sucralfate (Carafate)

Drug Class

Aluminium Sucrose Sulphate — GI Mucosal Protectant

Mechanism of Action

In acidic gastric pH, sucralfate polymerises and binds electrostatically to positively charged proteins at ulcer/erosion sites, forming a viscous, paste-like protective barrier. It also stimulates mucus and bicarbonate secretion, promotes prostaglandin E₂ synthesis, and binds bile acids and pepsin.

Primary Uses in Dogs

Gastric and duodenal ulcers, GI erosions from NSAID use, gastric haemorrhage, uraemic ulcers, oesophagitis, and prophylaxis against stress ulceration in critically ill patients.

Dosing Quick Reference

Indication Dose Frequency
GI ulcers/erosions 0.5–1 g q6–8h PO 30 min before food
Small dogs (< 10 kg) 0.25–0.5 g q6–8h PO
Post-NSAID GI upset 1 g q8h PO until resolved

Common Side Effects

  • Constipation (most common with repeated use)
  • Aluminium accumulation with renal failure and prolonged high-dose use
  • Interferes with absorption of other oral drugs (give sucralfate 2 hours apart from other medications)
  • Rare: aluminium-induced neurotoxicity with renal impairment

Monitoring

No routine bloodwork required for short-term use. Monitor aluminium levels in dogs with renal disease receiving prolonged sucralfate therapy.

⚠️ Give sucralfate on an empty stomach at least 30 minutes before food and at least 2 hours away from other oral medications for best efficacy. The tablets can be compounded into a suspension for ease of administration. Sucralfate is minimally absorbed — it acts locally in the GI tract.

What Is Sucralfate?

Sucralfate (aluminum sucrose octasulfate) is a locally-acting GI mucosal protectant with a unique mechanism: in an acidic environment (pH <4), it undergoes polymerisation and releases aluminium, forming a viscous paste that selectively binds to damaged mucosa (ulcer craters, erosions, inflamed epithelium) through electrostatic interactions with positively-charged proteins at injury sites. This creates a physical barrier protecting the mucosa from acid, pepsin, and bile salts for up to 6 hours per dose.

Sucralfate also stimulates prostaglandin E2 synthesis (cytoprotective), promotes mucus and bicarbonate secretion, adsorbs bile salts, and may have direct healing properties by binding epidermal growth factor (EGF) and delivering it to ulcer sites. It is not systemically absorbed to any significant degree — <5% is absorbed, making it extremely safe for use in dogs with organ dysfunction.

Key Pharmacological Properties

  • Mechanism: Acid-activated mucosal adhesion + barrier + prostaglandin stimulation + EGF binding
  • Systemic absorption: <5% — exceptionally safe profile
  • pH requirement: Needs gastric pH <4 for activation — give BEFORE acid suppressants, not after
  • Binding: Binds many drugs (fluoroquinolones, digoxin, tetracycline, ciprofloxacin) — separate by 2 hours
  • Forms: 1 g tablets (scored); 200 mg/mL suspension (compounded/some products)

Key Clinical Indications in Dogs

  • Gastric and duodenal ulcers (primary or secondary to NSAIDs/steroids)
  • Haemorrhagic gastroenteritis (HGE) / acute haemorrhagic diarrhoea syndrome (AHDS)
  • Reflux oesophagitis / megaesophagus-associated oesophagitis
  • Uraemic gastritis (chronic kidney disease)
  • Gastrointestinal ulcers secondary to mast cell tumours (histamine-mediated)
  • Post-surgical GI protection (e.g., after gastric surgery, pyloric stenosis repair)

How to Use This Calculator

  1. Enter your dog’s weight in kg or lbs — sucralfate dosing is often weight-banded rather than strictly weight-proportional
  2. Select the clinical indication — severity determines frequency (q6h vs q8h)
  3. Choose the formulation available (tablet or suspension)
  4. Select whether concurrent acid suppressant therapy is being used — this affects administration timing guidance
  5. Click Calculate for dose, frequency, amount, and timing schedule

🧮 Sucralfate Dose Calculator

Critical for administration timing

Sucralfate Dosing Result

Dose per administration

⏰ Sample Daily Administration Schedule

Critical Drug Interaction Timing

Sucralfate binds many drugs and reduces their absorption if given concurrently. Always separate sucralfate from the following by at least 2 hours:

Drug Category Examples Interaction
Fluoroquinolone antibiotics Enrofloxacin, ciprofloxacin, marbofloxacin Sucralfate binds → ↓ absorption (up to 80%)
Tetracyclines Doxycycline, oxytetracycline Chelation with aluminium → ↓ absorption
PPIs / H2 blockers Omeprazole, famotidine, ranitidine Higher gastric pH → ↓ sucralfate activation — give sucralfate first
Digoxin Digoxin Adsorption → ↓ absorption — separate strictly
Phenytoin Phenobarbital (partial) Reduced absorption — monitor levels
Fat-soluble vitamins Vitamins A, D, E, K Reduced absorption with chronic use

Frequently Asked Questions

Sucralfate is a prodrug activated by acid. In the fasting stomach, pH is typically 1–3, which is sufficient to polymerise sucralfate into its active gel form that adheres to ulcerated mucosa. When food is present, gastric pH rises to 4–6 (the buffering action of food), which reduces sucralfate’s ability to activate and form the protective barrier. Maximum efficacy requires administration at least 30–60 minutes before feeding or 2 hours after a meal.

Yes — sucralfate and PPIs are frequently used together for severe gastric ulcers, and the combination is more effective than either alone. However, the order of administration matters critically: give sucralfate first on an empty stomach, then wait 30–60 minutes before giving the PPI. If given together or if PPI is given first, the raised gastric pH from the PPI prevents sucralfate from activating into its gel form, significantly reducing efficacy.

Sucralfate tablets can be crushed and suspended in a small amount of water (5–10 mL) to form a slurry for easier oral administration — this is common practice in dogs reluctant to take tablets. Do not mix with food (it should be given on an empty stomach for best efficacy). Compounded suspensions (typically 200 mg/mL) are commercially available and may be more convenient for small dogs or long-term therapy. Check the suspension formulation does not contain antacids, as some preparations include aluminium hydroxide separately.

Duration depends on the underlying cause. For NSAID-induced ulcers: typically 4–8 weeks with NSAID discontinuation. For uraemic gastritis in CKD: may be used long-term (months to years) as the underlying cause persists. For oesophagitis: 4–6 weeks typically. For HGE/AHDS: 5–7 days of acute treatment. Endoscopic re-evaluation is the gold standard for confirming healing — particularly important when ulcers were associated with GI bleeding, perforation risk, or when signs don’t resolve as expected.

Generally yes, with monitoring. Sucralfate is minimally absorbed (<5%), making it very safe compared to systemically-absorbed GI drugs. However, the small amount of aluminium absorbed may accumulate in dogs with severe renal impairment (IRIS Stage 4 CKD) since aluminium is renally excreted. Long-term sucralfate use in severe CKD warrants periodic serum aluminium monitoring, though clinical aluminium toxicity from sucralfate alone is extremely rare in dogs.

Yes — sucralfate can cause constipation in dogs, particularly with long-term use or higher doses. This is due to the aluminium component, which reduces GI motility and can cause stool hardening. If constipation occurs, ensure adequate hydration, consider reducing dose frequency if clinically appropriate, or discuss lactulose or dietary fibre supplementation with your veterinarian. Sucralfate-induced constipation is generally mild and manageable.

References

  1. Plumb DC. Plumb’s Veterinary Drug Handbook, 9th ed. Wiley-Blackwell; 2018.
  2. Marks SL, et al. ACVIM consensus statement: support for rational administration of gastrointestinal protectants to dogs and cats. J Vet Intern Med. 2018;32(6):1823-1840.
  3. Papich MG. Saunders Handbook of Veterinary Drugs, 4th ed. Elsevier; 2016.
  4. Tams TR. Gastrointestinal ulcer disease. In: Ettinger SJ, ed. Textbook of Veterinary Internal Medicine. 7th ed. Saunders; 2010.
  5. Willard MD. Alimentary neoplasia in geriatric dogs and cats. Vet Clin North Am Small Anim Pract. 2012;42(4):693-706.